Contact


Mailing Address

Donate

Your tax deductible gift in any amount helps support our efforts to advocate for more research, better treatments, and ultimately, a cure for IH.

Donate

 

SomnusNooze Articles

YOU Power the Engine for #BeyondSleepy

Medical Advisory Board (MAB) and Scientific Advisory Board (SAB) volunteers: The Hypersomnia Foundation’s Medical and Scientific Advisory Boards, otherwise known as the MAB and SAB, are comprised of world experts in their fields of sleep research and clinical work. The CoRDS registry questions were shaped by...

Continue Reading

WEP Clinical – Expanded Access to Medications Not Yet Approved for General Prescription

Do you and your healthcare provider feel you might benefit from access to a medication that is not yet available/approved in your country or that is still in clinical trials? WEP Clinical* might be able to help you with this access. The Hypersomnia Foundation is...

Continue Reading

Arise Clinical Trial

CLINICAL TRIAL ENROLLING PATIENTS WITH IDIOPATHIC HYPERSOMNIA AND NARCOLEPSY TYPE 2 Balance Therapeutics is evaluating an investigational new drug BTD-001, to treat excessive daytime sleepiness in individuals diagnosed with Idiopathic Hypersomnia (IH) or Narcolepsy Type 2 (Na-2).  A Phase 2 clinical trial is currently enrolling Na-2 subjects at 26...

Continue Reading

Get “Somnusnooze”, HF’s monthly newsletter

Sign up to receive HF updates, news from the world of sleep research, first-person stories, and more.

Thank you for your interest in the Hypersomnia Foundation!